CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
Potassium Nitrate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01587950
NCT01587950Phase 1Completed

An Exploratory Study Investigating the Effects of a Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity

GlaxoSmithKline·interventional·Posted Apr 30, 2012·Updated Apr 28, 2015

In Brief

A Phase 1 clinical trial evaluating Potassium Nitrate and Placebo for Dentinal Hypersensitivity and Dental Pain. Completed, enrolled 12 participants across 1 site.

Detailed Summary

A randomized, controlled, double blind exploratory study to explore the effects of two different potassium nitrate concentrations and water on exposed dentine in reducing dentinal hypersensitivity. Solutions will be applied for either 2, 5 or 10 minutes and assessed by visual analogue scale (VAS) scores following evaporative (air) stimulus.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 30, 2012
Enrollment StartFeb 1, 2009
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.2 years ago

Interventions

Potassium Nitratedrug

250 μL of Potassium nitrate solution (either 5% or 2.5%)

Placebodrug

Sterile Water